Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| CGJIXCalvert US Large Cap Growth Rspnb Idx I | $83.07 | +1.34% | $1.1B | — |
| BAMPXBlackRock 40/60 Target Allocation Fund, Investor A | $14.47 | +0.21% | $818M | — |
| CGJAXCalvert US Large Cap Growth Rspnb Idx A | $82.11 | +1.33% | $1.1B | — |
| EEMAXColumbia Emerging Markets Fund | $21.89 | +2.10% | $927M | — |
| FAMEXFAM Dividend Focus Fund Investor |
No one on the platform currently holds CGJIX.
No tracked institution reports a position in CGJIX as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-11 | $2.2941 | 2025-12-12 |
| 2024-12-12 | $1.3834 | 2024-12-13 |
| 2023-12-14 | $0.2865 | 2023-12-15 |
No one on the platform has traded CGJIX yet.
| $55.93 |
| +0.76% |
| $632M |
| — |
| FCIRXNYLI PineStone International Equity Fund Class A | $18.96 | +1.07% | $661M | — |
| HGHAXThe Hartford Healthcare Fund Class A | $40.91 | -0.97% | $733M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.